As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity
Last year, Ozempic, Rybelsus and Wegovy had combined sales of about $21.1 billion globally – up 89% since 2022.
TOPIC
FORMAT
AUTHOR
RESEARCH AREA
Copyright 2024 Pew Research Center